How Breakthroughs in Immunotherapy are Helping Non-Small Cell Lung Cancer Patients Live Longer Ed hates cancer and he’ll tell you as much. He was diagnosed with non-small cell lung cancer, the same disease that took his mother. At the time he was diagnosed, Ed’s cancer had advanced to stage 3. From the moment he discovered he had cancer Ed knew he needed to go beyond traditional treatments to beat it. Ed’s oncologist asked him to consider trying IMFINZI (durvalumab). Ed’s cancer has now been eradicated and he believes immunotherapy is opening doors for patients to live longer. June is Cancer Immunotherapy Month! Click below to check out our content-filled Cancer Immunotherapy Month™ calendar, where we will educate the public about immunotherapy, raise awareness, and fuel vital fundraising efforts in the fight against cancer. Explore the Calendar Donate
